Frances Toneguzzo, Ph.D.

Frances Toneguzzo, Ph.D., is an experienced biotech executive and academic licensing professional, including serving as the Executive Director, Strategic Development for Partners HealthCare, where she led foreign and domestic collaborations involving technology development and educational relationships. She subsequently  served as the Executive Vice President at NantKwest an immunotherapy-based oncology company. She is currently focused on advancing Fiddlehead Foundation initiatives.

Brandy Houser, Ph.D.

Brandy previously worked at the MGH and Partners as well as at an Australian early stage investment fund, Brandon Capital Partners. Currently she is serving as the Site Head for Celdara Medical, LLC in New York, NY, a company focused on helping to accelerate the transition of academic research efforts into successful companies.  She has repositioned, financed and currently manages drug development programs for three separate early stage technologies.

Jean-Loup Romet Lemmone, M.D.

Jean-Loup Romet-Lemonne, M.D. is a third founding member of the Foundation bringing additional depth of international expertise in biotech development and a pioneer of Cancer Cellular Immunotherapy with 30 years as biotech entrepreneur both side of the Atlantic.

Matt Faria, Ph.D.

Matt’s research has focused on the interactions between nanomaterials and biological systems. Matt is an expert in the development of computational models as well as software engineering, and adds an engineering perspective to the team.